|
Sign In to gain access to subscriptions and/or personal tools.
|
Cellular Regulation of the Metabolism of Androgens in Rat Oral Mucosa. III. Activation of  4-3-ketosteroid-5 -A Ring Reductase Enzyme System by 5,5-Diphenylhydantoin
Jozef Vittek
Department of Medicine, New York Medical College, New York 10029, U.S.A., Department of Dentistry, New York Medical College, New York 10029, U.S.A.
Gary G. Gordon
Department of Medicine, New York Medical College, New York 10029, U.S.A., Department of Dentistry, New York Medical College, New York 10029, U.S.A.
Sydney C. Rappaport
Department of Medicine, New York Medical College, New York 10029, U.S.A., Department of Dentistry, New York Medical College, New York 10029, U.S.A.
A. Louis Southren
Department of Medicine, New York Medical College, New York 10029, U.S.A., Department of Dentistry, New York Medical College, New York 10029, U.S.A.
Systemic pretreatment of rats with diphenylhydantoin (DPH) or its addition into an in vitro assay increases 5 -reduction of testosterone by the oral mucosa. Enzyme kinetic studies showed that DPH binds to the enzyme and probably activates it by an allosteric mechanism.
REFERENCES
- Angelopoulos, A.P. and Goaz, P.N.: Incidence of diphenylhydantoin gingival hyperplasia, Oral Surg 34:898-906, 1972.
- Kapur, R.N.; Girgis, S.; Little, T.M. and Masotti, R.E.: Diphenylhydantoin-induced gingival hyperplasia: its relationship to dose and serum level, Develop Med Child Neurol 15:483-487, 1973.[Medline]
[Order article via Infotrieve]
- Soni, N.N.; Silberkweit, M.; Stricker, E. and Salamat, K.: Mitotic activity in human gingival epithelium associated with dilantin sodium therapy, Periodontics 5: 70-72,1967.[Medline]
[Order article via Infotrieve]
- Bhussry, B.R. and Saroja, R.: Effect of sodium diphenylhydantoinate on oral mucosa of rats, Proc Soc Exptl Biol and Med 113: 595-599, 1963.
- Hassell, T.M.; Page, R.C.; Narayan-An, A.S. and Cooper, C.G.: Diphenylhydantoin (Dilantin) gingival hyperplasia: Drug-induced abnormality of connective tissue, Proc Natl Acad Sci 73:2909-2912, 1976.[Abstract/Free Full Text]
- Keith, D.A.; Paz, M.A. and Gallop, P.M.: The effect of diphenylhydantoin on fibroblast cells in vitro, J Dent Res 54:121, 1975.[Abstract/Free Full Text]
- Werk, E.E.; Macgee, J. and Sholiton, L.J.: Effect of diphenylhydantoin on cortisol metabolism in man, J Clin Investig 43:1824-1835,1964.[Medline]
[Order article via Infotrieve]
- Choi, Y.; Thrasher, K.; Werk, E.E.; Sholiton, L.J. and Olinger, C.H.: Effect of diphenylhydantoin on cortisol kinetics in humans, J Pharmacol Exp Therap 176:27-34, 1971.[Abstract/Free Full Text]
- Bernstein, J.D. and Johnson, S.L.: Effects of diphenylhydantoin upon estrogen metabolism by liver microsomes of DDTtreated Japanese quail, Bull Env Contam Toxicol 10:309-314, 1973.[CrossRef][Medline]
[Order article via Infotrieve]
- Sholiton, L.J.; Werk, E.E. and Macgee, J.: The effect of diphenylhydantoin in vitro on the metabolism of testosterone by rat liver slices, Acta Endocr 56:490-498, 1967.
- Walshe, M.M.: Cutaneous drug effects in epilepsy. Trans St Johns Hosp Derm Soc 58:269-281,1972.[Medline]
[Order article via Infotrieve]
- Reynolds, E.H.: Chronic antiepileptic toxicity: A review, Epilepsia 16:319-352, 1975.[CrossRef][Medline]
[Order article via Infotrieve]
- Cunliffe, W.J. and Cotterie, J.A.: Major problems in dermatology. Vol. 6, 1975.
- Jenkins, J.S. and Ash, S.: The metabolism of testosterone by human skin in disorders of hair growth, J Endocr 59:345-351, 1973.[Abstract/Free Full Text]
- Kirschner, M.A. and Bardin, C.W.: Androgen production and metabolism in normal and virilized women, Metabolism 21: 667-690, 1972.[CrossRef][Medline]
[Order article via Infotrieve]
- Rosenfield, R.L.: Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects, J Clin Endocrinol Metab 32:717-728, 1971.[Abstract/Free Full Text]
- Tulchinsky, D. and Chopra, I.J.:Estrogen-androgen imbalance in patients with hirsutism and amenorrhea, J Clin Endocrinol Metab 39:164-169, 1974.[Abstract/Free Full Text]
- Werk, E.E.; Sholiton, L.J. and Olinger, C.P.: Amelioration of non-tumorous Cushing's syndrome by diphenylhydantoin, Int Congr Hormonal Steroids, Milan. Abstract, Int Congr Ster III, Excerpta Medica Found, p. 301, New York, 1966.
- Southren, A.L.; Vittek, J.; Weinstein, B.; Rappaport, S.C. and Gordon, G.G.: Effect of dilantin on the formation of 5-dihydrotestosterone and its binding to receptor protein in human gingiva, J Dent Res 57: Abstract 954, 1978.
- Vittek, J.; Altman, K.; Rappaport, S.C.; Gordon, G.G.; Hagedoorn, J.; and Southren, A.L.: Effect of progestins on androgen
 4-3-ketosteroid 5a-A-ring reductase system in rat oral mucosa, J Dent Res 57:511-519, 1978.[Abstract/Free Full Text] - Sholiton, L.J.; Werk, E.E. and Macgee, J.: The effect of diphenylhydantoin in vitro on the formation of polar metabolites of testosterone by rat liver, Acta Endocr 62:360-366,1969.
- Wortel, J.P.; Rao, G.S.; Osborn, J.C. and Hefferren, J.J.: Tissue distribution and covalent binding of 14C-diphenylhydantoin in normal and phenobarbital pretreated rats, J Dent Res 55:B288, 1976.
- Dixon, M. and Webb, E.C.: Enzymes, 2nd Ed. Acad. Press, New York 1964.
- Southren, A.L.; Rappaport, S.C.; Gordon, G.G.; and Vittek, J.: Specific 5-dihydrotestosterone receptors in human gingiva, J Clin Endocrinol Metab 47:1378-1382, 1978.[Abstract/Free Full Text]
Journal of Dental Research, Vol. 58, No. 2,
642-645 (1979)
DOI: 10.1177/00220345790580021901
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Vittek, P.R. Munnangi, G.G. Gordon, S.C. Rappaport, and A.L. Southren
The Effect of 5,5'-diphenylhydantoin on the Metabolism of 17{beta}-estradiol by Rat Oral Mucosa
Journal of Dental Research,
August 1, 1982;
61(8):
1010 - 1013.
[Abstract]
[PDF]
|
|
|
|
|
